Registry for patients with hairy cell leukemia
Clinical Research in Hairy Cell Leukemia: Surveillance and Documentation of Clinical Outcomes in a Rare Form of Adult Leukemia
Ohio State University Comprehensive Cancer Center · NCT02560883
This study is collecting information from people with hairy cell leukemia to help find better treatments and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ohio State University Comprehensive Cancer Center (other) |
| Locations | 6 sites (Miami, Florida and 5 other locations) |
| Trial ID | NCT02560883 on ClinicalTrials.gov |
What this trial studies
This registry aims to collect and centralize de-identified data from patients diagnosed with hairy cell leukemia to facilitate research and improve patient outcomes. By gathering information on symptoms, treatment complications, and disease progression, the registry will help identify effective treatments and potential new therapies. Collaborating with multiple institutions, the study emphasizes safeguarding patient confidentiality while enabling comprehensive data analysis. The ultimate goal is to enhance the quality of life for patients living with this rare form of leukemia.
Who should consider this trial
Good fit: Ideal candidates for this registry are adults diagnosed with classic or variant hairy cell leukemia.
Not a fit: Children and individuals without a diagnosis of hairy cell leukemia will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and better management of hairy cell leukemia.
How similar studies have performed: Other registries for rare diseases have shown success in improving patient outcomes and guiding research, indicating a promising approach for this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion: * Patients with classic hairy cell leukemia * Patients with the variant of hairy cell leukemia. Exclusion: * Children are excluded from the study, since Hairy Cell Leukemia wasn't described in children.
Where this trial is running
Miami, Florida and 5 other locations
- University of Miami/Soffer Clinical Research Center — Miami, Florida, United States (RECRUITING)
- Mayo Clinic — Rochester, Minnesota, United States (RECRUITING)
- University of Rochester /Wilmot Cancer Institute — Rochester, New York, United States (RECRUITING)
- Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States (RECRUITING)
- Peter MacCallum Cancer Center — Melbourne, Victoria, Australia (RECRUITING)
- Cancer Care Manitoba — Winnipeg, Manitoba, Canada (RECRUITING)
Study contacts
- Principal investigator: Michael Grever, MD — The Ohio State University Comprehensive Cancer Center
- Study coordinator: Hairy Cell Leukemia Research Data Registry
- Email: HCLRegistry@osumc.edu
- Phone: 614-685-4296
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Leukemia, Other, Hairy Cell